AngioDynamics, Inc. Announces Dennis Meteny to Retire as A Member of the Board of Directors, Member of the Compensation Committee and Chair of the Audit Committee, Effective January 31, 2024
January 22, 2024 at 07:30 am EST
Share
On January 16, 2024, Dennis Meteny announced his intention to retire and resign from his position as a member of the Board of Directors of AngioDynamics, Inc. and as a member of the Compensation Committee and chair of the Audit Committee, effective January 31, 2024. Mr. Meteny has served as a member of the Board since 2004 and his decision to retire and resign was not the result of any disagreement between Mr. Meteny and the Company on any matter relating to the Company?s operations, policies or practices. At this time, the Board does not intend to appoint a new director to fill the vacancy created by Mr. Meteny?s retirement and resignation, reducing the size of the Board to 8 directors.
AngioDynamics, Inc. is a transformative medical technology company. The Company is focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving quality of life for patients. It designs, manufactures, and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Its devices are generally used in minimally invasive, image-guided procedures. Its segments include Med Tech and Med Device. Its product categories include oncology, venous therapies, vascular interventions, and ports. Its oncology products include Model 1500X RF Generator, IsoLoc Endorectal Balloon, Habib 4X Laparoscopic Bipolar Resection Device, Habib 4X Bipolar Resection Device, and Alatus. Its venous therapies include VenaCure EVLT 1470 Pro Laser, VenaCure EVLT System, VenaCure EVLT Procedure Packs, and others.
AngioDynamics, Inc. Announces Dennis Meteny to Retire as A Member of the Board of Directors, Member of the Compensation Committee and Chair of the Audit Committee, Effective January 31, 2024
ANGIODYNAMICS, INC. 
